Jacky is a long-time contributor to Injury Lawyer News who believes that education is a powerful tool. She hopes to empower readers with knowledge about the pharmaceutical industry so that they may become their own best advocates.
The federal Zostavax lawsuits currently pending in a multidistrict litigation (MDL) are set to begin moving through the discovery process, according to a plan recently approved by the U.S. District Judge who is overseeing the MDL. Judge Harvey Bartle III is presiding in the U.S.... Read More
Research confirmed by the FDA suggests the use of the diabetes drug Invokana can increase the risk of lower limb amputations. Now, a more recent study suggests that the risk of amputations may extend to other diabetes drugs in the same class, including Jardiance and... Read More
Researchers from the renowned Mayo Clinic have published a study that suggests patients with chronic kidney disease may be at risk of an acute kidney injury when exposed to gadolinium dye. The acute kidney injury may become life-threatening and may require dialysis treatment. Gadolinium dye,... Read More
Camber Pharmaceuticals, Inc. and Hetero Drugs, Ltd. have been named as defendants in a class action lawsuit filed by a woman from Massachusetts regarding the contaminated valsartan pills. The class action lawsuit, filed by Veronica Longwell, seeks to represent all individuals who have purchased the... Read More
A few dozen Ethicon hernia mesh lawsuits have been selected for the initial discovery pool. From this pool, a handful of bellwether cases will be selected for early trial dates. These bellwether trials are intended to allow all involved parties to assess how juries tend... Read More
The family of a woman who died from excessive bleeding filed a wrongful death lawsuit against the makers of Pradaxa, claiming that the drug had led to the patient’s death. Recently, a federal jury in West Virginia agreed with the family’s claims. The jury ordered... Read More
As news of the valsartan scandal spreads and the FDA investigation picks up steam, a growing number of concerned patients have looked into filing lawsuits against the manufacturer of the contaminated drug. The problem with valsartan first became apparent in July 2018, when European regulators... Read More
Multiple plaintiffs who have filed gadolinium deposition disease lawsuits had filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to centralize the federal lawsuits in a multidistrict litigation (MDL). That motion was originally filed in July, with the plaintiffs’ counsel arguing for... Read More
